TY - JOUR T1 - Integrated single cell analysis of human lung fibrosis resolves cellular origins of predictive protein signatures in body fluids JF - medRxiv DO - 10.1101/2020.01.21.20018358 SP - 2020.01.21.20018358 AU - Christoph H. Mayr AU - Lukas M. Simon AU - Gabriela Leuschner AU - Meshal Ansari AU - Philipp E. Geyer AU - Ilias Angelidis AU - Maximilian Strunz AU - Pawandeep Singh AU - Nikolaus Kneidinger AU - Frank Reichenberger AU - Edith Silbernagel AU - Stephan Böhm AU - Heiko Adler AU - Anne Hilgendorff AU - Michael Lindner AU - Antje Prasse AU - Jürgen Behr AU - Matthias Mann AU - Oliver Eickelberg AU - Fabian J. Theis AU - Herbert B. Schiller Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/01/27/2020.01.21.20018358.abstract N2 - Single cell genomics enables characterization of disease specific cell states, while improvements in mass spectrometry workflows bring the clinical use of body fluid proteomics within reach. The correspondence of cell state changes in diseased organs to peripheral protein signatures is currently unknown. Here, we leverage single cell RNA-seq and proteomic analysis of large pulmonary fibrosis patient cohorts to identify disease specific changes on the cellular level and their corresponding reflection in body fluid proteomes. We discovered and validated transcriptional changes in 45 cell types across three patient cohorts that translated into distinct changes in the bronchoalveolar lavage fluid and plasma proteome. These protein signatures correlated with diagnosis, lung function, smoking and injury status. Specifically, the altered expression of a novel marker of lung health, CRTAC1, in alveolar epithelium is robustly reflected in patient plasma. Our findings have direct implications for future non-invasive prediction and monitoring of pathological cell state changes in patient organs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the German Center for Lung Research (DZL), the Helmholtz Association, the Max Planck Society, and the German Federal Ministry of Education and Research (BMBF), project Single Cell Genomics Network Germany.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCount tables of the Munich single cell cohort as well as all custom analysis code can be accessed at https://github.com/theislab/2020_Mayr. Proteome raw data and MaxQuant processing tables can be downloaded from the PRIDE repository under the accession number PXD017145 (BALF) and PXD017210 (plasma). ER -